HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

Plant-Based Vaccines

Plant-Based Vaccines

Plant-based vaccines represent an innovative approach to vaccine development, utilizing plants as bioreactors for producing antigens. This method harnesses the natural ability of plants to synthesize complex proteins, enabling the mass production of vaccine components that can stimulate an immune response. Plant-derived vaccines offer several advantages, including ease of production, cost-effectiveness, and stability at ambient temperatures, which is crucial for distribution in developing regions. Additionally, the use of plants minimizes the risk of contamination associated with traditional vaccine production methods. Research is ongoing to optimize the efficacy and delivery of these vaccines, with the potential to combat diseases in both humans and animals.

Committee Members
Speaker at Plant Biology and Biotechnology 2026 - P E Rajasekharan

P E Rajasekharan

ICAR-IIHR, India
Speaker at Plant Biology and Biotechnology 2026 - Valasia Iakovoglou

Valasia Iakovoglou

UNESCO chair Con-E-Ect, International Hellenic University, Greece
Speaker at Plant Biology and Biotechnology 2026 - Rameshkumar K B

Rameshkumar K B

Jawaharlal Nehru Tropical Botanic Garden and Research Institute, India
GPB 2026 Speakers
Speaker at Plant Biology and Biotechnology 2026 - Selina Sterup Moore
Selina Sterup Moore
Aarhus University, Denmark

Submit your abstract Today

Signup for updates

By submitting this form, you are consenting to receive emails and notifications from Magnus Group. You can revoke your consent to receive emails at any time by using the Safe Unsubscribe link, found at the bottom of every email

Watsapp